serena williams opens up about being on a glp-1 SerenaWilliams is opening her experience with the drug Zepbound. The recent public discourse around Williams's body—online commenters have noticed change in her physique and demanded to know how Wimbledon 2026: Why Serena Williams'

Based on these retrospective analyses, one could argue that all newly diagnosed, as well as established, type 2 diabetes patients should be started simultaneously, within a few weeks to months, on an SGLT2 inhibitor plus a GLP-1 receptor agonist

"Here's your daily reminder that Ozempic works," one video caption says

Do GLP-1 medications lower vitamin D levels

Still, it's worth confirming how your plan lists Foundayo (for example, if you later switch to a covered indication)

Quick Answer: GLP-1 receptor agonists do not directly increase fracture risk, but substantial weight loss during treatment may indirectly reduce bone mineral density at weight-bearing sites

Additionally, this option may have less availability or expensive